GACM
HAE icon

Global Alpha Capital Management’s Haemonetics HAE Stock Holding History

Global Alpha Capital Management’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-19,853
Closed -$968K – 60
2025
Q3 		$968K Sell
19,853
-7,600
-28% -$470K 0.06% 55
2025
Q2 		$2.05M Sell
27,453
-100
-0.4% -$6.62K 0.13% 49
2025
Q1 		$1.75M Buy
27,553
+10,452
+61% +$711K 0.13% 51
2024
Q4 		$1.34M Buy
17,101
+7,076
+71% +$568K 0.1% 54
2024
Q3 		$806K Buy
+10,025
New +$810K 0.05% 56

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Global Alpha Capital Management's HAE Position: Q4 2025 in Review

Global Alpha Capital Management sold out of Haemonetics (HAE) in Q4 2025, closing a stake of 19,853 shares — an estimated $968K sold.

Global Alpha Capital Management first reported a position in HAE in Q3 2024 and held it in 5 quarters. The position peaked at $2.05M in Q2 2025. 328 funds tracked by Wall St. Rank hold HAE as of Q4 2025.

  • Global Alpha Capital Management reported no remaining Haemonetics position as of Q4 2025 after selling out during the quarter.
  • Global Alpha Capital Management sold 19,853 Haemonetics shares in Q4 2025, an estimated $968K.
  • Global Alpha Capital Management first reported a position in Haemonetics in Q3 2024 and held it in 5 quarters.
  • Global Alpha Capital Management's Haemonetics position peaked at $2.05M in Q2 2025.
  • 328 funds tracked by Wall St. Rank held Haemonetics as of Q4 2025.

Based on Global Alpha Capital Management's 13F filing for Q4 2025, filed 11 Feb 2026.